140 related articles for article (PubMed ID: 38610930)
1. Novel systemic therapy against malignant pleural mesothelioma.
Mancuso MR; Neal JW
Transl Lung Cancer Res; 2017 Jun; 6(3):295-314. PubMed ID: 28713675
[TBL] [Abstract][Full Text] [Related]
2. The past, present, and future of targeted therapeutic approaches in patients with diffuse pleural mesotheliomas.
Offin M; Fitzgerald B; Zauderer MG; Doroshow D
J Cancer Metastasis Treat; 2023; 9():. PubMed ID: 38895597
[TBL] [Abstract][Full Text] [Related]
3. Targeted Therapy in Mesotheliomas: Uphill All the Way.
Bertoli E; De Carlo E; Bortolot M; Stanzione B; Del Conte A; Spina M; Bearz A
Cancers (Basel); 2024 May; 16(11):. PubMed ID: 38893092
[TBL] [Abstract][Full Text] [Related]
4. Emerging New Targets in Systemic Therapy for Malignant Pleural Mesothelioma.
Yun KM; Bazhenova L
Cancers (Basel); 2024 Mar; 16(7):. PubMed ID: 38610930
[TBL] [Abstract][Full Text] [Related]
5. Heterogeneous Contributing Factors in MPM Disease Development and Progression: Biological Advances and Clinical Implications.
Tolani B; Acevedo LA; Hoang NT; He B
Int J Mol Sci; 2018 Jan; 19(1):. PubMed ID: 29342862
[TBL] [Abstract][Full Text] [Related]
6. Molecular Characterization of Mesothelioma: Impact of Histologic Type and Site of Origin on Molecular Landscape.
Dagogo-Jack I; Madison RW; Lennerz JK; Chen KT; Hopkins JF; Schrock AB; Ritterhouse LL; Lester A; Wharton KA; Mino-Kenudson M; Danziger N; Hung YP; Mata DA; Ross JS
JCO Precis Oncol; 2022 Jun; 6():e2100422. PubMed ID: 35704798
[TBL] [Abstract][Full Text] [Related]
7. Isolated
Osmanbeyoglu HU; Palmer D; Sagan A; Sementino E; Becich MJ; Testa JR
Cancers (Basel); 2022 Nov; 14(22):. PubMed ID: 36428720
[TBL] [Abstract][Full Text] [Related]
8. Malignant Pleural Mesothelioma: State-of-the-Art on Current Therapies and Promises for the Future.
Nicolini F; Bocchini M; Bronte G; Delmonte A; Guidoboni M; Crinò L; Mazza M
Front Oncol; 2019; 9():1519. PubMed ID: 32039010
[TBL] [Abstract][Full Text] [Related]
9. Emerging biological therapies for the treatment of malignant pleural mesothelioma.
Davis AP; Kao SC; Clarke SJ; Boyer M; Pavlakis N
Expert Opin Emerg Drugs; 2021 Jun; 26(2):179-192. PubMed ID: 33945357
[No Abstract] [Full Text] [Related]
10. Targeted Approaches to Treatment of Pleural Mesothelioma: A Review.
Dagogo-Jack I
JCO Precis Oncol; 2023 Sep; 7():e2300344. PubMed ID: 37992257
[TBL] [Abstract][Full Text] [Related]
11. Functional enhancement of mesothelin-targeted TRuC-T cells by a PD1-CD28 chimeric switch receptor.
McCarthy D; Lofgren M; Watt A; Horton H; Kieffer-Kwon P; Ding J; Kobold S; Baeuerle PA; Hofmeister R; Gutierrez DA; Tighe R
Cancer Immunol Immunother; 2023 Dec; 72(12):4195-4207. PubMed ID: 37848682
[TBL] [Abstract][Full Text] [Related]
12. Effects of Combined Therapeutic Targeting of AXL and ATR on Pleural Mesothelioma Cells.
Hirai S; Yamada T; Katayama Y; Ishida M; Kawachi H; Matsui Y; Nakamura R; Morimoto K; Horinaka M; Sakai T; Sekido Y; Tokuda S; Takayama K
Mol Cancer Ther; 2024 Feb; 23(2):212-222. PubMed ID: 37802502
[TBL] [Abstract][Full Text] [Related]
13. MRTX1719 Is an MTA-Cooperative PRMT5 Inhibitor That Exhibits Synthetic Lethality in Preclinical Models and Patients with MTAP-Deleted Cancer.
Engstrom LD; Aranda R; Waters L; Moya K; Bowcut V; Vegar L; Trinh D; Hebbert A; Smith CR; Kulyk S; Lawson JD; He L; Hover LD; Fernandez-Banet J; Hallin J; Vanderpool D; Briere DM; Blaj A; Marx MA; Rodon J; Offin M; Arbour KC; Johnson ML; Kwiatkowski DJ; Jänne PA; Haddox CL; Papadopoulos KP; Henry JT; Leventakos K; Christensen JG; Shazer R; Olson P
Cancer Discov; 2023 Nov; 13(11):2412-2431. PubMed ID: 37552839
[TBL] [Abstract][Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
